United Therapeutic Shares Rocketing Higher Following FDA Approval of Orenitram, JP Morgan Upgrade

Shares of United Therapeutic (NASDAQ: UTHR ) are up more than 23 percent just after Monday morning's opening bell, breaking to a new high over $108. United Therapeutic announced on Friday that the United States Food and Drug Administration approved Orenitram (treprostinil) Extended-Release Tablets for the treatment of pulmonary arterial